Abstract

BackgroundFrailty is common in older patients affected by chronic kidney disease (CKD). Since gut microbiota (gMB) may contribute to frailty, we explored possible associations between gMB and frailty in CKD.MethodsWe studied 64 CKD patients (stage 3b-4), categorized as frail (F, 38) and not frail (NF, 26) according to Fried criteria, and 15 controls (C), all older than 65 years. In CKD we assessed serum C-reactive protein, blood neutrophil/lymphocyte ratio, Malnutrition-inflammation Score (MIS); gMB was studied by denaturing gel gradient electrophoresis (DGGE), high-throughput sequencing (16S r-RNA gene), and quantitative real-time PCR (RT-PCR).ResultsNo differences in alpha diversity between CKD and C and between F and NF patients emerged, but high-throughput sequencing showed significantly higher abundance of potentially noxious bacteria (Citrobacter, Coprobacillus, etc) and lower abundance of saccharolytic and butyrate-producing bacteria (Prevotella spp., Faecalibacterium prausnitzii, Roseburia spp.), in CKD respect to C. Mogibacteriaceae family and Oscillospira genus abundance was positively related to inflammatory indices in the whole CKD cohort, while that of Akkermansia, Ruminococcus and Eubacterium genera was negatively related. Compared with NF, in F there was a higher abundance of some bacteria (Mogibacteriacee, Coriobacteriacee, Eggerthella, etc), many of which have been described as more abundant in other diseases.ConclusionsThese results suggest that inflammation and frailty could be associated to gMB modifications in CKD.

Highlights

  • Frailty is highly frequent in patients affected by chronic kidney disease (CKD) (14–68%), its prevalence increases with age and progression of kidney disease, and it has been associated with worse quality of life and poor outcomes [1]

  • Mogibacteriaceae family and Oscillospira genus abundance was positively related to inflammatory indices in the whole CKD cohort, while that of Akkermansia, Ruminococcus and Eubacterium genera was negatively related

  • These results suggest that inflammation and frailty could be associated to gut microbiota (gMB) modifications in CKD

Read more

Summary

Introduction

Frailty is highly frequent in patients affected by chronic kidney disease (CKD) (14–68%), its prevalence increases with age and progression of kidney disease, and it has been associated with worse quality of life and poor outcomes [1]. GMB changes have been described both in frail subjects and in CKD patients, with potential worsening of their clinical outcomes [5,6]. Changes of gMB composition, with increased Enterobacteria and reduced Lactobacillaceae and Prevotellaceae, have been reported in CKD, but only in few studies mainly focused on end stage renal disease (ESRD) [7,8]. Frailty is common in older patients affected by chronic kidney disease (CKD). Since gut microbiota (gMB) may contribute to frailty, we explored possible associations between gMB and frailty in CKD

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call